Michael S Magee
Overview
Explore the profile of Michael S Magee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
563
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Xiang B, Snook A, Magee M, Waldman S
Discov Med
. 2013 Jun;
15(84):301-8.
PMID: 23725603
Antitumor immunotherapy for colorectal cancer has been studied at the bench and bedside for decades. Some clinical trials of cancer immunotherapy have demonstrated a potential benefit for patients with colorectal...
12.
Magee M, Snook A, Marszalowicz G, Waldman S
Biomark Med
. 2013 Feb;
7(1):23-35.
PMID: 23387482
Throughout the last century medical advances in cancer treatment in the fields of surgery, radiation therapy and chemotherapy have greatly impacted patients' survival rates. Nevertheless, cancer remains a significant cause...
13.
Augello M, Burd C, Birbe R, McNair C, Ertel A, Magee M, et al.
J Clin Invest
. 2012 Dec;
123(1):493-508.
PMID: 23257359
Cyclin D1b is a splice variant of the cell cycle regulator cyclin D1 and is known to harbor divergent and highly oncogenic functions in human cancer. While cyclin D1b is...
14.
Lin J, Valentino M, Marszalowicz G, Magee M, Li P, Snook A, et al.
Toxins (Basel)
. 2011 Nov;
2(8):2028-54.
PMID: 22069671
Heat-stable toxins (STs) produced by enterotoxigenic bacteria cause endemic and traveler's diarrhea by binding to and activating the intestinal receptor guanylyl cyclase C (GC-C). Advances in understanding the biology of...
15.
Snook A, Magee M, Marszalowicz G, Schulz S, Waldman S
Cancer Immunol Immunother
. 2011 Nov;
61(5):713-23.
PMID: 22057677
Guanylyl cyclase C (GUCY2C) is the index cancer mucosa antigen, an emerging class of immunotherapeutic targets for the prevention of recurrent metastases originating in visceral epithelia. GUCY2C is an autoantigen...
16.
Snook A, Magee M, Waldman S
Immunol Res
. 2011 Nov;
51(2-3):161-9.
PMID: 22038530
For the last decade, we have focused on guanylyl cyclase C (GUCY2C) as a potentially ideal target antigen for colorectal cancer immunotherapy. GUCY2C is expressed only in intestinal epithelial cells...
17.
Valentino M, Lin J, Snook A, Li P, Kim G, Marszalowicz G, et al.
J Clin Invest
. 2011 Aug;
121(9):3578-88.
PMID: 21865642
Intestinal enteroendocrine cells are critical to central regulation of caloric consumption, since they activate hypothalamic circuits that decrease appetite and thereby restrict meal size by secreting hormones in response to...